TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT04930653: Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Sponsor: City of Hope Medical Center · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 34 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$831,600

Rescue Site Savings

+$554,400

Unlock Full NCT04930653 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04930653 Rescue Dossier →